Loading…
image

Report Scope & Overview:

Pharmacovigilance Market was valued at USD 6.70 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030.

Pharmacovigilance Market Overview:
Global Pharmacovigilance Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Pharmacovigilance Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Pharmacovigilance market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Pharmacovigilance market research is expected to experience further growth and innovation in the coming years.

DESCIMG1

Pharmacovigilance Market Key Trends

Increasing Regulatory Requirements: Regulatory agencies worldwide are imposing stricter guidelines and regulations to enhance drug safety monitoring and reporting. This has led to an increased demand for pharmacovigilance services and solutions to comply with the evolving regulatory landscape.

Growing Drug Development and Clinical Trials: The pharmaceutical industry continues to witness significant growth in drug development activities and clinical trials. Pharmacovigilance plays a vital role in monitoring the safety of investigational drugs and identifying any potential adverse events during the trial phase, thus driving the demand for pharmacovigilance services.

Adoption of Technological Advancements: The pharmacovigilance industry is adopting advanced technologies such as artificial intelligence (AI), machine learning (ML), natural language processing (NLP), and big data analytics. These technologies enable efficient processing of large volumes of data, improved signal detection, automated case processing, and enhanced safety monitoring.

Increasing Outsourcing of Pharmacovigilance Activities: Pharmaceutical companies are increasingly outsourcing their pharmacovigilance activities to specialized service providers. Outsourcing helps companies reduce costs, access specialized expertise, and ensure compliance with regulatory requirements. This trend has led to the growth of the pharmacovigilance outsourcing market.

Focus on Signal Detection and Risk Management: Signal detection and risk management are critical components of pharmacovigilance. There is a growing emphasis on proactive monitoring of adverse events and potential safety signals to identify and manage risks associated with marketed drugs. Pharmacovigilance activities are expanding beyond post-marketing surveillance to include risk management strategies and benefit-risk assessments.

Collaboration and Partnerships: Collaboration between pharmaceutical companies, contract research organizations (CROs), academic institutions, regulatory agencies, and pharmacovigilance service providers is increasing. Such collaborations facilitate knowledge sharing, access to diverse data sources, and the development of standardized processes and best practices in pharmacovigilance.

 Patient-Centric Approach: Patient-centric pharmacovigilance is gaining importance, focusing on actively involving patients in adverse event reporting, collecting patient-reported outcomes, and monitoring medication safety from the patient's perspective. This approach aims to improve patient safety and engagement in drug safety monitoring.


Market Segmentations:

Global Pharmacovigilance Market: By Company
• Eli Lilly and Company
• ICON
• Elsevier
• Chiltern
• Atlantic Research Group
• Mapi Group
• Accenture
• Clinquest Group
• GSK
• PRA Health Sciences

Global Pharmacovigilance Market: By Type
• Chemotherapy
• Contract Outsourcing

Global Pharmacovigilance Market: By Application
• Pharma and Biotech Companies
• Contract Research Organizations (CROs)
• Business Process Outsourcing (BPO) Firms
• Others

Global Pharmacovigilance Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Pharmacovigilance market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Report Attribute/MetricDetails
Market Size 2022USD 6.70 billion
Compound Annual Growth Rate (CAGR)7.0%(2023-2032)
Base Year2023
Forecast Period2023-2032
Historical Data2018-2020
Forecast UnitsValue (USD Million)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
Segments CoveredBy Company, By Type, By Application and By Region
Key Companies Profiled• Eli Lilly and Company
• ICON
• Elsevier
• Chiltern
• Atlantic Research Group
• Mapi Group
• Accenture
• Clinquest Group
• GSK
• PRA Health Sciences
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request


Reasons to Purchase Pharmacovigilance Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.

Objectives of Pharmacovigilance Market Study:
The objectives of Pharmacovigilance market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Pharmacovigilance market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Pharmacovigilance market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.

Frequently Asked Questions

  Pharmacovigilance Market was valued at USD 6.70 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030.

  The key factors driving the growth of the pharmacovigilance market include increasing regulations and requirements for drug safety monitoring, growing complexity of drug safety data, rising incidence of adverse drug reactions (ADRs), and the need to ensure patient safety and regulatory compliance.

  North America holds a significant share of the pharmacovigilance market due to well-established healthcare infrastructure and stringent regulatory guidelines. However, the Asia Pacific region is expected to witness significant growth due to the increasing focus on drug safety and surveillance, growing pharmaceutical industry, and outsourcing of pharmacovigilance services.

  Pharmacovigilance involves the collection, monitoring, assessment, and reporting of adverse drug reactions (ADRs) and other drug-related problems. It aims to ensure the safety and efficacy of medications throughout their lifecycle, from pre-marketing clinical trials to post-marketing surveillance.

  The key challenges faced by the pharmacovigilance market include increasing volumes of data, the complexity of drug safety regulations, resource constraints, the need for qualified professionals, maintaining data privacy and confidentiality, and the integration of new technologies for efficient data management.

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Chemotherapy
1.2.3 Contract Outsourcing
1.3 Market by Application
1.3.1 Global Pharmacovigilance Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Pharma and Biotech Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Business Process Outsourcing (BPO) Firms
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance Market Perspective (2017-2032)
2.2 Pharmacovigilance Growth Trends by Region
2.2.1 Global Pharmacovigilance Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Pharmacovigilance Historic Market Size by Region (2017-2023)
2.2.3 Pharmacovigilance Forecasted Market Size by Region (2023-2032)
2.3 Pharmacovigilance Market Dynamics
2.3.1 Pharmacovigilance Industry Trends
2.3.2 Pharmacovigilance Market Drivers
2.3.3 Pharmacovigilance Market Challenges
2.3.4 Pharmacovigilance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance Players by Revenue
3.1.1 Global Top Pharmacovigilance Players by Revenue (2017-2023)
3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2017-2023)
3.2 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance Revenue
3.4 Global Pharmacovigilance Market Concentration Ratio
3.4.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2022
3.5 Pharmacovigilance Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance Product Solution and Service
3.7 Date of Enter into Pharmacovigilance Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance Breakdown Data by Type
4.1 Global Pharmacovigilance Historic Market Size by Type (2017-2023)
4.2 Global Pharmacovigilance Forecasted Market Size by Type (2023-2032)
5 Pharmacovigilance Breakdown Data by Application
5.1 Global Pharmacovigilance Historic Market Size by Application (2017-2023)
5.2 Global Pharmacovigilance Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Pharmacovigilance Market Size (2017-2032)
6.2 North America Pharmacovigilance Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Pharmacovigilance Market Size by Country (2017-2023)
6.4 North America Pharmacovigilance Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacovigilance Market Size (2017-2032)
7.2 Europe Pharmacovigilance Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Pharmacovigilance Market Size by Country (2017-2023)
7.4 Europe Pharmacovigilance Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Market Size (2017-2032)
8.2 Asia-Pacific Pharmacovigilance Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Pharmacovigilance Market Size by Region (2017-2023)
8.4 Asia-Pacific Pharmacovigilance Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacovigilance Market Size (2017-2032)
9.2 Latin America Pharmacovigilance Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Pharmacovigilance Market Size by Country (2017-2023)
9.4 Latin America Pharmacovigilance Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Market Size (2017-2032)
10.2 Middle East & Africa Pharmacovigilance Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Pharmacovigilance Market Size by Country (2017-2023)
10.4 Middle East & Africa Pharmacovigilance Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Pharmacovigilance Introduction
11.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2017-2023)
11.1.5 Eli Lilly and Company Recent Development
11.2 ICON
11.2.1 ICON Company Detail
11.2.2 ICON Business Overview
11.2.3 ICON Pharmacovigilance Introduction
11.2.4 ICON Revenue in Pharmacovigilance Business (2017-2023)
11.2.5 ICON Recent Development
11.3 Elsevier
11.3.1 Elsevier Company Detail
11.3.2 Elsevier Business Overview
11.3.3 Elsevier Pharmacovigilance Introduction
11.3.4 Elsevier Revenue in Pharmacovigilance Business (2017-2023)
11.3.5 Elsevier Recent Development
11.4 Chiltern
11.4.1 Chiltern Company Detail
11.4.2 Chiltern Business Overview
11.4.3 Chiltern Pharmacovigilance Introduction
11.4.4 Chiltern Revenue in Pharmacovigilance Business (2017-2023)
11.4.5 Chiltern Recent Development
11.5 Atlantic Research Group
11.5.1 Atlantic Research Group Company Detail
11.5.2 Atlantic Research Group Business Overview
11.5.3 Atlantic Research Group Pharmacovigilance Introduction
11.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2017-2023)
11.5.5 Atlantic Research Group Recent Development
11.6 Mapi Group
11.6.1 Mapi Group Company Detail
11.6.2 Mapi Group Business Overview
11.6.3 Mapi Group Pharmacovigilance Introduction
11.6.4 Mapi Group Revenue in Pharmacovigilance Business (2017-2023)
11.6.5 Mapi Group Recent Development
11.7 Accenture
11.7.1 Accenture Company Detail
11.7.2 Accenture Business Overview
11.7.3 Accenture Pharmacovigilance Introduction
11.7.4 Accenture Revenue in Pharmacovigilance Business (2017-2023)
11.7.5 Accenture Recent Development
11.8 Clinquest Group
11.8.1 Clinquest Group Company Detail
11.8.2 Clinquest Group Business Overview
11.8.3 Clinquest Group Pharmacovigilance Introduction
11.8.4 Clinquest Group Revenue in Pharmacovigilance Business (2017-2023)
11.8.5 Clinquest Group Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Pharmacovigilance Introduction
11.9.4 GSK Revenue in Pharmacovigilance Business (2017-2023)
11.9.5 GSK Recent Development
11.10 PRA Health Sciences
11.10.1 PRA Health Sciences Company Detail
11.10.2 PRA Health Sciences Business Overview
11.10.3 PRA Health Sciences Pharmacovigilance Introduction
11.10.4 PRA Health Sciences Revenue in Pharmacovigilance Business (2017-2023)
11.10.5 PRA Health Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences

Request Sample